Chipericumin E - Compound Card

Chipericumin E

Select a section from the left sidebar

Chipericumin E

Structure
Zoomed Structure
  • Family: Plantae - Hypericaceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Sesquiterpene
Canonical Smiles C1(=C([C@@](C(=O)[C@@]2(C1=O)C[C@@H]1[C@@H]([C@@](C2)(C)O)CC[C@@]1(O)C)(CC=C(C)C)C)O)C(=O)C(C)C
InChI InChI=1S/C26H38O6/c1-14(2)8-10-23(5)20(28)18(19(27)15(3)4)21(29)26(22(23)30)12-17-16(25(7,32)13-26)9-11-24(17,6)31/h8,15-17,28,31-32H,9-13H2,1-7H3/t16-,17+,23-,24-,25-,26-/m0/s1
InChIKey PIDFRBSCCDEYLQ-NFZZFWQLSA-N
Formula C26H38O6
HBA 6
HBD 3
MW 446.58
Rotatable Bonds 4
TPSA 111.9
LogP 3.85
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 32
Formal Charge 0
Fraction CSP3 0.73
Exact Mass 446.27
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Hypericum riparium Hypericaceae Plantae 269018

Showing of synonyms

  • Tala MF, Talontsi FM, et al. (2015). Antimicrobial and cytotoxic constituents from native Cameroonian medicinal plant Hypericum riparium.. Fitoterapia,2015, 102, 149-155. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: C1CCC(CC2)C1CC23C(=O)C=CCC3=O

Level: 0

Mol. Weight: 446.58 g/mol

Antibacterial

Absorption

Caco-2 (logPapp)
-4.45
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.78
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.48

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.8
Plasma Protein Binding
95.73
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
1.04
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
-1.27
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.81
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
6.68
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Toxic
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Toxic
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-29.83
Rat (Acute)
3.75
Rat (Chronic Oral)
2.48
Fathead Minnow
3.95
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
446.0
Hydration Free Energy
-5.05
Log(D) at pH=7.4
2.75
Log(P)
4.06
Log S
-4.41
Log(Vapor Pressure)
-8.07
Melting Point
177.18
pKa Acid
5.06
pKa Basic
2.11
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Type IV / VI secretion system DotU domain-containing protein Q9KN50 Q9KN50_VIBCH Vibrio cholerae serotype O1 3 0.7817
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7627
Aldo-keto reductase family 1 member C2 P52895 AK1C2_HUMAN Homo sapiens 3 0.7283
Vitamin D-binding protein P02774 VTDB_HUMAN Homo sapiens 2 0.7188
Acetylcholinesterase P21836 ACES_MOUSE Mus musculus 2 0.7057
Aldo-keto reductase family 1 member D1 P51857 AK1D1_HUMAN Homo sapiens 3 0.7016

Download SDF